The newest of these semi-local developments is the Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio diagnostic test, which is the first test of its kind to diagnose Alzheimer's via blood samples. UNLV's Kirk Kerkorian School of Medicine contributed research to the test, which the FDA approved last year.

Heart disease remains the leading cause of death in the U.S., but its impact isn’t equal across communities. African Americans are significantly more likely to die from heart disease—even though many have similar or lower cholesterol levels. So, what’s driving this gap, and what can be done to close it?

Nevada’s aging population is growing and so are diagnoses for brain diseases. 8 News Now spoke with Dr. Samantha John with the University of Nevada, Las Vegas. She says our state now has one of the fastest-rising rates of neurodegenerative disease.

Trouble concentrating can show up in everyday life in ways that range from mildly frustrating to seriously disruptive, and the symptoms can look different from person to person.

Compared to the days of the coronavirus pandemic a few years ago, customer activity in any pharmacy in the U.S. state of Virginia appears normal. Shelves are well stocked with medications, many of them marked with discounted prices. Yet despite this calm scene, there is growing anticipation of a major crisis in what are known as global supply chains—one that could turn this quiet picture upside down.

A new study published on Sunday in the European Heart Journal found that people who get even small amounts of vigorous exercise each day may be less likely to develop eight major diseases.